Abstract
AIMS: To investigate the immunoreactivity of a range of melanocytic lesions, both benign and malignant, with the monoclonal antibody VS38. This was recently described as a marker of reactive/neoplastic plasma cells and, therefore, is useful in the diagnosis of plasmacytoma/myeloma and lymphomas with plasmacytic differentiation. This study was prompted by the recent observation that a plasmacytoid melanoma arising in the nasal cavity was strongly immunoreactive with VS38, which was therefore a potential source of major diagnostic error. METHODS: The Streptavidin-peroxidase complex technique was used on paraffin wax embedded sections of 167 melanocytic lesions. Diaminobenzidine (DAB) was used as chromogen for non-pigmented or lightly pigmented lesions and nickel/DAB for more heavily pigmented lesions. RESULTS: Positive immunostaining for VS38 was seen in 14.5% (10/69) of benign naevi (including 40% (four of 10) of Spitz naevi), 10.5% (two of 19) of dysplastic naevi/in situ melanomas, 92% (35/38) of primary cutaneous melanomas, 100% (four of four) of primary mucosal melanomas, 91.7% (33/36) of recurrent/metastatic melanomas, and 100% (one of one) of clear cell sarcomas of soft tissues. CONCLUSIONS: VS38 immunostaining is frequently positive in primary and recurrent/metastatic malignant melanoma and is also reactive less commonly with benign naevi. These results should be borne in mind when this recently described marker of normal/neoplastic plasma cells is used to identify tumour lineage, particularly in tumours arising at unusual sites, such as in the nasal cavity. The possibility of malignant melanoma should be actively considered and excluded in any undifferentiated tumour which shows VS38 immunoreactivity.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bishop P. W., Menasce L. P., Yates A. J., Win N. A., Banerjee S. S. An immunophenotypic survey of malignant melanomas. Histopathology. 1993 Aug;23(2):159–166. doi: 10.1111/j.1365-2559.1993.tb00474.x. [DOI] [PubMed] [Google Scholar]
- Bittesini L., Dei Tos A. P., Fletcher C. D. Metastatic malignant melanoma showing a rhabdoid phenotype: further evidence of a non-specific histological pattern. Histopathology. 1992 Feb;20(2):167–170. doi: 10.1111/j.1365-2559.1992.tb00947.x. [DOI] [PubMed] [Google Scholar]
- Buley I. D., Gatter K. C., Kelly P. M., Heryet A., Millard P. R. Granular cell tumours revisited. An immunohistological and ultrastructural study. Histopathology. 1988 Mar;12(3):263–274. doi: 10.1111/j.1365-2559.1988.tb01941.x. [DOI] [PubMed] [Google Scholar]
- Duray P. H., Palazzo J., Gown A. M., Ohuchi N. Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with S-100 protein in paraffin sections. Cancer. 1988 Jun 15;61(12):2460–2468. doi: 10.1002/1097-0142(19880615)61:12<2460::aid-cncr2820611213>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
- Facchetti F., Bertalot G., Grigolato P. G. KP1 (CD 68) staining of malignant melanomas. Histopathology. 1991 Aug;19(2):141–145. doi: 10.1111/j.1365-2559.1991.tb00004.x. [DOI] [PubMed] [Google Scholar]
- Mackie R. M., Campbell I., Turbitt M. L. Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J Clin Pathol. 1984 Apr;37(4):367–372. doi: 10.1136/jcp.37.4.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miettinen M., Franssila K. Immunohistochemical spectrum of malignant melanoma. The common presence of keratins. Lab Invest. 1989 Dec;61(6):623–628. [PubMed] [Google Scholar]
- Toublanc M., Grossin M., Benrejeb N., Tousignant J., Crickx B., Belaich S., Bocquet L. Un cas de mélanome malin exprimant les marqueurs des cellules épithéliales en immunohistochimie sur coupes en paraffine. Ann Pathol. 1990;10(1):34–36. [PubMed] [Google Scholar]
- Truong L. D., Rangdaeng S., Cagle P., Ro J. Y., Hawkins H., Font R. L. The diagnostic utility of desmin. A study of 584 cases and review of the literature. Am J Clin Pathol. 1990 Mar;93(3):305–314. doi: 10.1093/ajcp/93.3.305. [DOI] [PubMed] [Google Scholar]
- Turley H., Jones M., Erber W., Mayne K., de Waele M., Gatter K. VS38: a new monoclonal antibody for detecting plasma cell differentiation in routine sections. J Clin Pathol. 1994 May;47(5):418–422. doi: 10.1136/jcp.47.5.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vennegoor C., Calafat J., Hageman P., van Buitenen F., Janssen H., Kolk A., Rümke P. Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C-3. Int J Cancer. 1985 Mar 15;35(3):287–295. doi: 10.1002/ijc.2910350302. [DOI] [PubMed] [Google Scholar]
- Yates A. J., Banerjee S. S., Bishop P. W., Graham K. E. HMB-45 in non-melanocytic tumours. Histopathology. 1993 Nov;23(5):477–478. doi: 10.1111/j.1365-2559.1993.tb00499.x. [DOI] [PubMed] [Google Scholar]